Your browser is no longer supported. Please, upgrade your browser.
OraSure Technologies, Inc.
Index- P/E- EPS (ttm)-0.07 Insider Own1.00% Shs Outstand71.76M Perf Week3.84%
Market Cap697.54M Forward P/E17.82 EPS next Y0.55 Insider Trans-1.38% Shs Float70.57M Perf Month-6.62%
Income-3.80M PEG- EPS next Q0.05 Inst Own97.30% Short Float9.09% Perf Quarter-32.01%
Sales198.70M P/S3.51 EPS this Y-182.50% Inst Trans0.41% Short Ratio5.50 Perf Half Y-23.02%
Book/sh5.55 P/B1.75 EPS next Y-2.15% ROA-3.50% Target Price17.00 Perf Year-42.29%
Cash/sh2.92 P/C3.33 EPS next 5Y20.00% ROE-3.90% 52W Range8.58 - 19.75 Perf YTD-8.08%
Dividend- P/FCF- EPS past 5Y-28.80% ROI-4.10% 52W High-50.73% Beta-0.25
Dividend %- Quick Ratio5.50 Sales past 5Y7.50% Gross Margin62.40% 52W Low13.40% ATR0.47
Employees570 Current Ratio6.20 Sales Q/Q26.60% Oper. Margin-4.50% RSI (14)47.42 Volatility6.42% 4.75%
OptionableYes Debt/Eq0.00 EPS Q/Q-33.90% Profit Margin-7.20% Rel Volume0.91 Prev Close9.86
ShortableYes LT Debt/Eq0.00 EarningsMay 05 AMC Payout- Avg Volume1.17M Price9.73
Recom2.30 SMA200.88% SMA50-6.30% SMA200-22.34% Volume1,046,257 Change-1.32%
Aug-21-20Initiated Evercore ISI Outperform $22
Aug-10-20Initiated JP Morgan Neutral $18
Aug-10-20Initiated Citigroup Buy $18
Aug-07-20Upgrade Raymond James Mkt Perform → Outperform $16
Jun-25-20Initiated Lake Street Buy $19
Apr-21-20Resumed Stephens Equal-Weight $14
Oct-23-18Resumed Raymond James Mkt Perform
Jul-16-18Downgrade Stephens Overweight → Equal-Weight
Nov-02-17Downgrade Jefferies Buy → Hold
Feb-09-17Upgrade Raymond James Mkt Perform → Outperform
Jun-13-16Downgrade Raymond James Outperform → Mkt Perform
Nov-05-15Reiterated Mizuho Buy $12 → $8
May-07-15Downgrade JMP Securities Mkt Outperform → Mkt Perform
Jan-23-15Reiterated Mizuho Buy $10 → $12
Jun-12-14Reiterated Canaccord Genuity Buy $10 → $11
Jun-11-14Reiterated Mizuho Buy $9 → $10
Dec-21-12Initiated Mizuho Buy $9
Aug-08-12Upgrade Barrington Research Mkt Perform → Outperform $12.50
Jul-05-12Downgrade Barrington Research Outperform → Mkt Perform
Mar-27-12Initiated JMP Securities Mkt Outperform $15
May-10-21 06:00AM  
May-06-21 01:01AM  
May-05-21 05:25PM  
Apr-30-21 04:01PM  
Apr-28-21 12:34PM  
Mar-30-21 07:00AM  
Mar-10-21 10:29AM  
Mar-01-21 08:31PM  
Feb-26-21 10:09AM  
Feb-24-21 04:01PM  
Feb-18-21 06:00AM  
Feb-10-21 12:31PM  
Jan-29-21 06:00AM  
Jan-28-21 08:02AM  
Jan-27-21 08:55AM  
Jan-26-21 07:57AM  
Jan-25-21 06:00AM  
Jan-21-21 09:46AM  
Jan-14-21 08:34AM  
Jan-08-21 06:00AM  
Jan-05-21 06:00AM  
Dec-23-20 06:00AM  
Dec-21-20 04:01PM  
Nov-30-20 07:00AM  
Nov-12-20 07:00AM  
Nov-09-20 03:52PM  
Nov-06-20 08:59AM  
Nov-04-20 06:05PM  
Nov-03-20 07:00AM  
Oct-28-20 12:32PM  
Oct-21-20 06:00AM  
Oct-20-20 10:17AM  
Oct-19-20 11:44AM  
Oct-08-20 08:51AM  
Oct-05-20 12:23PM  
Sep-24-20 06:00AM  
Sep-15-20 12:00PM  
Sep-03-20 04:30PM  
Aug-27-20 04:30PM  
Aug-21-20 09:32AM  
Aug-11-20 12:39PM  
Aug-05-20 07:15PM  
Aug-04-20 10:59AM  
Jul-31-20 12:15PM  
Jul-29-20 12:33PM  
Jul-22-20 06:00AM  
Jun-25-20 08:00AM  
Jun-23-20 12:52PM  
Jun-17-20 07:00AM  
Jun-16-20 08:21AM  
Jun-10-20 08:00AM  
Jun-08-20 08:00AM  
Jun-03-20 08:50PM  
Jun-02-20 11:15PM  
Jun-01-20 04:01PM  
May-29-20 07:00AM  
May-26-20 06:00AM  
May-22-20 07:00AM  
May-15-20 06:00AM  
May-14-20 06:00AM  
May-12-20 08:00AM  
May-07-20 10:31AM  
May-06-20 04:00PM  
May-05-20 06:00AM  
May-04-20 06:00AM  
May-02-20 10:56AM  
Apr-29-20 12:33PM  
Apr-09-20 06:00AM  
Apr-08-20 01:18PM  
Apr-06-20 06:00AM  
Apr-02-20 09:35AM  
Mar-27-20 07:20AM  
Mar-19-20 09:17AM  
Feb-26-20 06:00AM  
Feb-21-20 10:04AM  
Feb-20-20 07:06AM  
OraSure Technologies, Inc., together with its subsidiaries, develops, manufactures, markets, and sells oral fluid diagnostic products and specimen collection devices in the United States, Europe, and internationally. The company operates in two segments, Diagnostics and Molecular Solutions. The company also offers other diagnostic products, such as immunoassays and other in vitro diagnostic tests. The company's principal products include OraQuick Rapid HIV test, OraQuick In-Home HIV test, OraQuick HIV self-test, OraQuick HCV rapid antibody test, OraQuick Ebola rapid antigen test, OraSure oral fluid collection device used in conjunction with screening and confirmatory tests for HIV-1 antibodies; Intercept drug testing systems; immunoassay tests and reagents; and Q.E.D. saliva alcohol test. It also offers genomic products under the Oragene and ORAcollect brands; microbiome collection products; and GenoFIND services, a suite of genomic services. In addition, the company offers ORAcollect, RNA and OMNIgene, and RAL collection devices for use in connection with COVID-19 molecular testing; manufactures and sells kits that are used to collect, stabilize, transport, and store samples of genetic material for molecular testing in the consumer genetic, clinical genetic, academic research, infectious disease diagnostics, pharmacogenomics, personalized medicine, microbime, and animal genetics markets. The company markets its products to clinical laboratories, hospitals, clinics, community-based organizations and other public health organizations, distributors, government agencies, physicians' offices, and commercial and industrial entities. OraSure Technologies, Inc. was incorporated in 2000 and is based in Bethlehem, Pennsylvania.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Weber Kathleen GallagherEVP & BU Lead - MolecularDec 23Sale11.7610,000117,60096,544Jan 04 05:48 PM